Categories
Alembic Pharmaceuticals Limited — Updates, 22-05-2026: Press Release
22-05-2026 · 10:59 am
Alembic Pharma secured USFDA final approval for Levothyroxine Sodium Tablets across multiple strengths. This drug targets an estimated US$ 1,869 million market, offering significant revenue potential.
No comments yet. Be the first to comment!